Dashboard
Manage Tickers

KEYKEYCORP /NEW/

NYSE key.com


$ 16.88 $ 0.14 (0.84 %)    

Thursday, 29-Aug-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.89 $ -0.69 (-0.15 %)
DIA $ 413.95 $ 2.57 (0.62 %)
SPY $ 559.30 $ 0.05 (0.01 %)
TLT $ 97.51 $ -0.32 (-0.33 %)
GLD $ 232.94 $ 1.20 (0.52 %)
$ 16.88
$ 16.84
$ 16.86 x 3,600
$ 16.88 x 5,200
$ 16.59 - $ 17.00
$ 8.96 - $ 17.00
12,771,422
na
15.92B
$ 1.52
$ 18.49
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-26-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-04-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-02-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-22-2021 12-31-2020 10-K
16 11-03-2020 09-30-2020 10-Q
17 08-03-2020 06-30-2020 10-Q
18 05-04-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-25-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 11-01-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 02-24-2016 12-31-2015 10-K
36 11-02-2015 09-30-2015 10-Q
37 08-03-2015 06-30-2015 10-Q
38 05-05-2015 03-31-2015 10-Q
39 03-02-2015 12-31-2014 10-K
40 11-04-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

key---analyzing-keycorps-short-interest
(KEY) - Analyzing KeyCorp's Short Interest
08/26/2024 13:45:14

jefferies-maintains-buy-on-keycorp-raises-price-target-to-19
Jefferies Maintains Buy on KeyCorp, Raises...
08/19/2024 16:08:13

Jefferies analyst Ken Usdin maintains KeyCorp (NYSE:KEY) with a Buy and raises the price target from $18 to $19.

morgan-stanley-maintains-equal-weight-on-keycorp-raises-price-target-to-20
Morgan Stanley Maintains Equal-Weight on K...
08/14/2024 11:56:21

Morgan Stanley analyst Manan Gosalia maintains KeyCorp (NYSE:KEY) with a Equal-Weight and raises the price target from $18 t...

rbc-capital-reiterates-outperform-on-keycorp-maintains-17-price-target
RBC Capital Reiterates Outperform on KeyCo...
08/13/2024 16:15:01

RBC Capital analyst Gerard Cassidy reiterates KeyCorp (NYSE:KEY) with a Outperform and maintains $17 price target.

starbucks-to-rally-around-43-here-are-10-top-analyst-forecasts-for-tuesday
Starbucks To Rally Around 43%? Here Are 10...
08/13/2024 13:28:02

citigroup-maintains-buy-on-keycorp-raises-price-target-to-19
Citigroup Maintains Buy on KeyCorp, Raises...
08/13/2024 13:13:41

Citigroup analyst Keith Horowitz maintains KeyCorp (NYSE:KEY) with a Buy and raises the price target from $18 to $19.

wedbush-maintains-neutral-on-keycorp-raises-price-target-to-17
Wedbush Maintains Neutral on KeyCorp, Rais...
08/13/2024 12:43:20

Wedbush analyst David Chiaverini maintains KeyCorp (NYSE:KEY) with a Neutral and raises the price target from $16 to $17.

us-stocks-trim-gains-as-iran-mulls-attack-on-israel-gold-oil-rally-whats-driving-markets-monday
US Stocks Trim Gains As Iran Mulls Attack ...
08/12/2024 17:00:48

Wall Street turns negative due to geopolitical risks. Gold rises 1.5% and stocks edge higher. Scotiabank acquires minority stak...

ke-holdings-keycorp-revance-therapeutics-starbucks-and-other-big-stocks-moving-higher-on-monday
KE Holdings, KeyCorp, Revance Therapeutics...
08/12/2024 14:09:35

Core News & Articles
Market-Moving News for August 12th
08/12/2024 12:21:29

KEY: 24% | Scotiabank Acquires 14.9% Stake in KeyCorp With $2.8B Strategic Investment ASND: 11% | Ascendia Pharma shares are tr...

why-is-keycorp-stock-shooting-higher-today
Why Is KeyCorp Stock Shooting Higher Today?
08/12/2024 11:59:40

KeyCorp receives a strategic investment from Scotiabank, expected to boost CET1 capital ratio and increase tangible book value ...

nasdaq-sp-500-futures-climb-after-volatile-week-as-traders-eye-inflation-data-and-retail-earnings-strategist-says-not-cpi-but-this-data-can-give-people-lot-of-conviction
Nasdaq, S&P 500 Futures Climb After Volati...
08/12/2024 11:31:35

The resilience of the market was in full display on Monday after last week’s “historical comeback” by the market. The major ind...

Core News & Articles
Scotiabank Acquires 14.9% Stake in KeyCorp...
08/12/2024 10:03:23

KeyCorp (NYSE:KEY) today announced it has reached an agreement under which The Bank of Nova Scotia ("Scotiabank") (TSX:...

jim-cramer-this-energy-stock-is-a-buy-stay-away-from-dexcom
Jim Cramer: This Energy Stock Is A Buy, St...
08/08/2024 13:29:44

The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is....

morgan-stanley-maintains-equal-weight-on-keycorp-raises-price-target-to-18
Morgan Stanley Maintains Equal-Weight on K...
08/05/2024 17:22:45

Morgan Stanley analyst Manan Gosalia maintains KeyCorp (NYSE:KEY) with a Equal-Weight and raises the price target from $16 t...

top-5-financials-stocks-that-may-fall-off-a-cliff-this-month
Top 5 Financials Stocks That May Fall Off ...
07/29/2024 12:33:34

regional-bank-performance-goldman-sachs-breaks-down-q2-2024-earnings
Regional Bank Performance: Goldman Sachs B...
07/19/2024 16:31:29

In a recent analyst note by Goldman Sachs, the outlook for several regional banks were evaluated. The banks examined include Ke...

rbc-capital-maintains-outperform-on-keycorp-raises-price-target-to-17
RBC Capital Maintains Outperform on KeyCor...
07/19/2024 15:43:15

RBC Capital analyst Robert Kwan maintains KeyCorp (NYSE:KEY) with a Outperform and raises the price target from $16 to $17.

da-davidson-maintains-buy-on-keycorp-raises-price-target-to-18
DA Davidson Maintains Buy on KeyCorp, Rais...
07/19/2024 15:38:56

DA Davidson analyst Peter Winter maintains KeyCorp (NYSE:KEY) with a Buy and raises the price target from $16 to $18.

wedbush-maintains-neutral-on-keycorp-raises-price-target-to-16
Wedbush Maintains Neutral on KeyCorp, Rais...
07/19/2024 14:14:06

Wedbush analyst David Chiaverini maintains KeyCorp (NYSE:KEY) with a Neutral and raises the price target from $15 to $16.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION